1. Home
  2. REVB vs CETX Comparison

REVB vs CETX Comparison

Compare REVB & CETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REVB
  • CETX
  • Stock Information
  • Founded
  • REVB 2020
  • CETX 1998
  • Country
  • REVB United States
  • CETX United States
  • Employees
  • REVB N/A
  • CETX N/A
  • Industry
  • REVB Biotechnology: Pharmaceutical Preparations
  • CETX EDP Services
  • Sector
  • REVB Health Care
  • CETX Technology
  • Exchange
  • REVB Nasdaq
  • CETX Nasdaq
  • Market Cap
  • REVB 2.8M
  • CETX 2.3M
  • IPO Year
  • REVB N/A
  • CETX 1998
  • Fundamental
  • Price
  • REVB $2.92
  • CETX $1.32
  • Analyst Decision
  • REVB
  • CETX
  • Analyst Count
  • REVB 0
  • CETX 0
  • Target Price
  • REVB N/A
  • CETX N/A
  • AVG Volume (30 Days)
  • REVB 147.3K
  • CETX 41.5K
  • Earning Date
  • REVB 05-09-2025
  • CETX 05-13-2025
  • Dividend Yield
  • REVB N/A
  • CETX N/A
  • EPS Growth
  • REVB N/A
  • CETX N/A
  • EPS
  • REVB N/A
  • CETX N/A
  • Revenue
  • REVB N/A
  • CETX $63,725,617.00
  • Revenue This Year
  • REVB N/A
  • CETX $19.77
  • Revenue Next Year
  • REVB N/A
  • CETX $15.00
  • P/E Ratio
  • REVB N/A
  • CETX N/A
  • Revenue Growth
  • REVB N/A
  • CETX N/A
  • 52 Week Low
  • REVB $2.36
  • CETX $1.14
  • 52 Week High
  • REVB $60.80
  • CETX $4,179.00
  • Technical
  • Relative Strength Index (RSI)
  • REVB 45.77
  • CETX 42.85
  • Support Level
  • REVB $2.76
  • CETX $1.16
  • Resistance Level
  • REVB $3.62
  • CETX $1.53
  • Average True Range (ATR)
  • REVB 0.41
  • CETX 0.10
  • MACD
  • REVB 0.02
  • CETX 0.02
  • Stochastic Oscillator
  • REVB 34.12
  • CETX 35.73

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded in a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security system. The company's operating segment includes, Security segment, Industrial Services segment and the corporate segment. The security segment provides end to end security to all industrial, corporate and governmental security via owned subsidiary Vicon. Whereas AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment. It geographically operates in USA, UK and India, with maximum of revenue from USA.

Share on Social Networks: